RPO LLC’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-14,222	Closed	-$23.5K	–	45
2024 Q4	$23.5K	Buy	+14,222	New	+$23.5K	0.02%	67
2024 Q1	–	Sell	-12,307	Closed	-$46K	–	61
2023 Q4	$46K	Buy	+12,307	New	+$46K	0.07%	77